Increased toll-like receptor activity in patients with metabolic syndrome

Ishwarlal Jialal, Beverley A. Huet, Harmeet Kaur, Alexander Chien, Sridevi Devaraj

Research output: Contribution to journalArticle

105 Citations (Scopus)

Abstract

OBJECTIVE - The metabolic syndrome (MetS) is highly prevalent and confers an increased risk for diabetes and cardiovascular disease (CVD). While MetS is a proinflammatory state, there is a paucity of data on cellular inflammation in MetS. Toll-like receptors (TLRs) are classical pattern recognition receptors of the innate immune response. RESEARCH DESIGN AND METHODS - The aim of this study was to examine monocyte TLR2 and TLR4 in MetS patients without diabetes or CVD and control subjects since both of the receptors have been implicated in atherosclerosis and insulin resistance. Fasting blood was obtained for TLR expression and activity. RESULTS - Circulating levels of high-sensitivity C-reactive protein, interleukin (IL)-1β, IL-6, IL-8, and soluble tumor necrosis factor receptor 1 (sTNFR1) were significantly increased in MetS versus control subjects following adjustment for waist circumference. There was a significant increase in both TLR2 and TLR4 surface expression and mRNA on monocytes after adjustment for waist circumference. In addition to increased nuclear factor-κB nuclear binding, there was significantly increased release of IL-1β, IL-6, and IL-8 in MetS versus control subjects following priming of the monocytes with lipopolysaccharides. While both plasma free fatty acids and endotoxin were increased in MetS, they correlated significantly with TLR4 only. CONCLUSIONS - In conclusion, we make the novel observation that both TLR2 and TLR4 expression and activity are increased in the monocytes of patients with MetS and could contribute to increased risk for diabetes and CVD.

Original languageEnglish (US)
Pages (from-to)900-904
Number of pages5
JournalDiabetes Care
Volume35
Issue number4
DOIs
StatePublished - Apr 2012

Fingerprint

Toll-Like Receptors
Monocytes
Cardiovascular Diseases
Waist Circumference
Interleukin-8
Interleukin-1
Interleukin-6
Pattern Recognition Receptors
Tumor Necrosis Factor Receptors
Nonesterified Fatty Acids
Innate Immunity
Endotoxins
C-Reactive Protein
Lipopolysaccharides
Insulin Resistance
Fasting
Atherosclerosis
Research Design
Observation
Inflammation

ASJC Scopus subject areas

  • Internal Medicine
  • Endocrinology, Diabetes and Metabolism
  • Advanced and Specialized Nursing

Cite this

Increased toll-like receptor activity in patients with metabolic syndrome. / Jialal, Ishwarlal; Huet, Beverley A.; Kaur, Harmeet; Chien, Alexander; Devaraj, Sridevi.

In: Diabetes Care, Vol. 35, No. 4, 04.2012, p. 900-904.

Research output: Contribution to journalArticle

Jialal, Ishwarlal ; Huet, Beverley A. ; Kaur, Harmeet ; Chien, Alexander ; Devaraj, Sridevi. / Increased toll-like receptor activity in patients with metabolic syndrome. In: Diabetes Care. 2012 ; Vol. 35, No. 4. pp. 900-904.
@article{187d5e321d174f7d926bcdd2e809e680,
title = "Increased toll-like receptor activity in patients with metabolic syndrome",
abstract = "OBJECTIVE - The metabolic syndrome (MetS) is highly prevalent and confers an increased risk for diabetes and cardiovascular disease (CVD). While MetS is a proinflammatory state, there is a paucity of data on cellular inflammation in MetS. Toll-like receptors (TLRs) are classical pattern recognition receptors of the innate immune response. RESEARCH DESIGN AND METHODS - The aim of this study was to examine monocyte TLR2 and TLR4 in MetS patients without diabetes or CVD and control subjects since both of the receptors have been implicated in atherosclerosis and insulin resistance. Fasting blood was obtained for TLR expression and activity. RESULTS - Circulating levels of high-sensitivity C-reactive protein, interleukin (IL)-1β, IL-6, IL-8, and soluble tumor necrosis factor receptor 1 (sTNFR1) were significantly increased in MetS versus control subjects following adjustment for waist circumference. There was a significant increase in both TLR2 and TLR4 surface expression and mRNA on monocytes after adjustment for waist circumference. In addition to increased nuclear factor-κB nuclear binding, there was significantly increased release of IL-1β, IL-6, and IL-8 in MetS versus control subjects following priming of the monocytes with lipopolysaccharides. While both plasma free fatty acids and endotoxin were increased in MetS, they correlated significantly with TLR4 only. CONCLUSIONS - In conclusion, we make the novel observation that both TLR2 and TLR4 expression and activity are increased in the monocytes of patients with MetS and could contribute to increased risk for diabetes and CVD.",
author = "Ishwarlal Jialal and Huet, {Beverley A.} and Harmeet Kaur and Alexander Chien and Sridevi Devaraj",
year = "2012",
month = "4",
doi = "10.2337/dc11-2375",
language = "English (US)",
volume = "35",
pages = "900--904",
journal = "Diabetes Care",
issn = "1935-5548",
publisher = "American Diabetes Association Inc.",
number = "4",

}

TY - JOUR

T1 - Increased toll-like receptor activity in patients with metabolic syndrome

AU - Jialal, Ishwarlal

AU - Huet, Beverley A.

AU - Kaur, Harmeet

AU - Chien, Alexander

AU - Devaraj, Sridevi

PY - 2012/4

Y1 - 2012/4

N2 - OBJECTIVE - The metabolic syndrome (MetS) is highly prevalent and confers an increased risk for diabetes and cardiovascular disease (CVD). While MetS is a proinflammatory state, there is a paucity of data on cellular inflammation in MetS. Toll-like receptors (TLRs) are classical pattern recognition receptors of the innate immune response. RESEARCH DESIGN AND METHODS - The aim of this study was to examine monocyte TLR2 and TLR4 in MetS patients without diabetes or CVD and control subjects since both of the receptors have been implicated in atherosclerosis and insulin resistance. Fasting blood was obtained for TLR expression and activity. RESULTS - Circulating levels of high-sensitivity C-reactive protein, interleukin (IL)-1β, IL-6, IL-8, and soluble tumor necrosis factor receptor 1 (sTNFR1) were significantly increased in MetS versus control subjects following adjustment for waist circumference. There was a significant increase in both TLR2 and TLR4 surface expression and mRNA on monocytes after adjustment for waist circumference. In addition to increased nuclear factor-κB nuclear binding, there was significantly increased release of IL-1β, IL-6, and IL-8 in MetS versus control subjects following priming of the monocytes with lipopolysaccharides. While both plasma free fatty acids and endotoxin were increased in MetS, they correlated significantly with TLR4 only. CONCLUSIONS - In conclusion, we make the novel observation that both TLR2 and TLR4 expression and activity are increased in the monocytes of patients with MetS and could contribute to increased risk for diabetes and CVD.

AB - OBJECTIVE - The metabolic syndrome (MetS) is highly prevalent and confers an increased risk for diabetes and cardiovascular disease (CVD). While MetS is a proinflammatory state, there is a paucity of data on cellular inflammation in MetS. Toll-like receptors (TLRs) are classical pattern recognition receptors of the innate immune response. RESEARCH DESIGN AND METHODS - The aim of this study was to examine monocyte TLR2 and TLR4 in MetS patients without diabetes or CVD and control subjects since both of the receptors have been implicated in atherosclerosis and insulin resistance. Fasting blood was obtained for TLR expression and activity. RESULTS - Circulating levels of high-sensitivity C-reactive protein, interleukin (IL)-1β, IL-6, IL-8, and soluble tumor necrosis factor receptor 1 (sTNFR1) were significantly increased in MetS versus control subjects following adjustment for waist circumference. There was a significant increase in both TLR2 and TLR4 surface expression and mRNA on monocytes after adjustment for waist circumference. In addition to increased nuclear factor-κB nuclear binding, there was significantly increased release of IL-1β, IL-6, and IL-8 in MetS versus control subjects following priming of the monocytes with lipopolysaccharides. While both plasma free fatty acids and endotoxin were increased in MetS, they correlated significantly with TLR4 only. CONCLUSIONS - In conclusion, we make the novel observation that both TLR2 and TLR4 expression and activity are increased in the monocytes of patients with MetS and could contribute to increased risk for diabetes and CVD.

UR - http://www.scopus.com/inward/record.url?scp=84862059730&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84862059730&partnerID=8YFLogxK

U2 - 10.2337/dc11-2375

DO - 10.2337/dc11-2375

M3 - Article

VL - 35

SP - 900

EP - 904

JO - Diabetes Care

JF - Diabetes Care

SN - 1935-5548

IS - 4

ER -